MEMBER'S LOGINX
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
- Home
- Research It
- Compare Company
- International - indian pharma
- DISHMAN PHARMA - ADCOCK INGRAM (S. Africa)
DISHMAN PHARMA vs ADCOCK INGRAM (S. Africa) - Comparison Results
DISHMAN PHARMA Change
Dishman Pharmaceuticals is involved in the manufacture of APIs (active pharmaceutical ingredients), intermediates, quaternary compounds and fine chemicals. Besides this, the company is a significant player in the CRAMS (Contract Research and Manufact... More
ADCOCK INGRAM (S. Africa)
Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More
Financials
 DISHMAN PHARMA  ADCOCK INGRAM |
| EQUITY SHARE DATA | |||||
|---|---|---|---|---|---|
| DISHMAN PHARMA Mar-16 |
ADCOCK INGRAM Jun-14 |
DISHMAN PHARMA/ ADCOCK INGRAM |
5-Yr Chart Click to enlarge
|
||
| High | Rs | 374 | 381 | - | |
| Low | Rs | 129 | 275 | - | |
| Sales per share (Unadj.) | Rs | 197.8 | 113.2 | - | |
| Earnings per share (Unadj.) | Rs | 21.2 | -28.5 | - | |
| Cash flow per share (Unadj.) | Rs | 34.7 | -23.6 | - | |
| Dividends per share (Unadj.) | Rs | 2.00 | 0 | - | |
| Dividend yield (eoy) | % | 0.8 | 0 | - | |
| Book value per share (Unadj.) | Rs | 179.9 | 88.9 | - | |
| Shares outstanding (eoy) | m | 80.69 | 168.78 | - | |
| Bonus/Rights/Conversions | - | - | - | ||
| Price / Sales ratio | x | 1.3 | 2.9 | 44.0% | |
| Avg P/E ratio | x | 11.9 | -11.5 | -103.3% | |
| P/CF ratio (eoy) | x | 7.2 | -13.9 | -52.3% | |
| Price / Book Value ratio | x | 1.4 | 3.7 | 37.9% | |
| Dividend payout | % | 9.4 | 0 | - | |
| Avg Mkt Cap | Rs m | 20,306 | 55,292 | 36.7% | |
| No. of employees | `000 | 0.8 | 4.3 | 19.3% | |
| Total wages/salary | Rs m | 5,355 | 3,470 | 154.3% | |
| Avg. sales/employee | Rs Th | 19,252.7 | 4,451.4 | 432.5% | |
| Avg. wages/employee | Rs Th | 6,459.5 | 808.4 | 799.1% | |
| Avg. net profit/employee | Rs Th | 2,064.1 | -1,121.7 | -184.0% | |
| INCOME DATA | |||||
|---|---|---|---|---|---|
| Net Sales | Rs m | 15,961 | 19,110 | 83.5% | |
| Other income | Rs m | 265 | 134 | 198.3% | |
| Total revenues | Rs m | 16,226 | 19,244 | 84.3% | |
| Gross profit | Rs m | 4,103 | -3,312 | -123.9% | |
| Depreciation | Rs m | 1,091 | 825 | 132.2% | |
| Interest | Rs m | 944 | 518 | 182.4% | |
| Profit before tax | Rs m | 2,334 | -4,520 | -51.6% | |
| Minority Interest | Rs m | 0 | -13 | 0.0% | |
| Prior Period Items | Rs m | 1 | 0 | - | |
| Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
| Tax | Rs m | 624 | 282 | 220.8% | |
| Profit after tax | Rs m | 1,711 | -4,815 | -35.5% | |
| Gross profit margin | % | 25.7 | -17.3 | -148.4% | |
| Effective tax rate | % | 26.7 | -6.2 | -427.7% | |
| Net profit margin | % | 10.7 | -25.2 | -42.5% | |
| BALANCE SHEET DATA | |||||
|---|---|---|---|---|---|
| Current assets | Rs m | 11,018 | 13,997 | 78.7% | |
| Current liabilities | Rs m | 9,517 | 7,875 | 120.9% | |
| Net working cap to sales | % | 9.4 | 32.0 | 29.4% | |
| Current ratio | x | 1.2 | 1.8 | 65.1% | |
| Inventory Days | Days | 110 | 111 | 99.6% | |
| Debtors Days | Days | 35 | 124 | 28.1% | |
| Net fixed assets | Rs m | 16,304 | 8,159 | 199.8% | |
| Share capital | Rs m | 161 | 89 | 181.9% | |
| Net worth | Rs m | 14,516 | 14,999 | 96.8% | |
| Long term debt | Rs m | 4,189 | 5,271 | 79.5% | |
| Total assets | Rs m | 29,805 | 28,335 | 105.2% | |
| Interest coverage | x | 3.5 | -7.7 | -44.9% | |
| Debt to equity ratio | x | 0.3 | 0.4 | 82.1% | |
| Sales to assets ratio | x | 0.5 | 0.7 | 79.4% | |
| Return on assets | % | 8.9 | -15.2 | -58.7% | |
| Return on equity | % | 11.8 | -32.1 | -36.7% | |
| Return on capital | % | 17.5 | -19.8 | -88.5% | |
| CASH FLOW | |||||
|---|---|---|---|---|---|
| From Operations | Rs m | 2,786 | 1,631 | 170.8% | |
| From Investments | Rs m | -1,529 | -501 | 305.3% | |
| From Financial Activity | Rs m | -941 | 4,784 | -19.7% | |
| Net Cashflow | Rs m | 316 | 5,914 | 5.3% | |
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.25 Rs / ZAR
Compare DISHMAN PHARMA With: ACTAVIS (US) MYLAN (US) TEVA PHARMA (Israel)
Compare DISHMAN PHARMA With: AUROBINDO PHARMA WOCKHARDT SHASUN PHARMA DR. DATSONS LABS ELDER PHARMA
Today's Market
Sensex Ends 244 Points Lower, Nifty Ends Below 14,300; UltraTech Cement & HCL Tech Top Losers(Closing)
Indian share markets witnessed volatile trading activity throughout the day today and ended lower.
Related Views On News
Most Popular
India: Recovery Stalled by Vaccine Games? (The Honest Truth)
Apr 13, 2021Ajit Dayal on how India's vaccine strategy will impact the markets.
A Stock with 700% Return Potential Comes with Additional Payoffs (Profit Hunter)
Apr 15, 2021Narayana Murthy was one of the first unicorn founders to get the backing of this entity...
11x Bankruptcy to Bluechip Stock: A Rare India Revival Story (Profit Hunter)
Apr 16, 2021There is no stopping this 11-bagger stock from significant upside.
Why Did the Market Crash on Monday? (Fast Profits Daily)
Apr 13, 2021In this video, I'll you what I think is the real reason behind yesterday's market crash.
A Warning About Bubbles (Fast Profits Daily)
Apr 16, 2021Those who don't learn from financial history are doomed to lose their money.
More
